Vaccinia Related Kinase 2 (VRK2) ELISA Kits

VRK2 encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. Zusätzlich bieten wir Ihnen VRK2 Antikörper (54) und VRK2 Proteine (6) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
VRK2 7444 Q86Y07
VRK2 69922 Q8BN21
Anti-Ratte VRK2 VRK2 360991  
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen

Top VRK2 ELISA Kits auf

Showing 2 out of 4 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Anbieter Lieferzeit Preis Details
Human < 0.094 ng/mL 0.156 ng/mL - 10 ng/mL   96 Tests Anmelden zum Anzeigen 11 bis 18 Tage
Maus < 0.094 ng/mL 0.156 ng/mL - 10 ng/mL   96 Tests Anmelden zum Anzeigen 11 bis 18 Tage

Weitere ELISA Kits für VRK2 Interaktionspartner

Human Vaccinia Related Kinase 2 (VRK2) Interaktionspartner

  1. Structural characterization of human vaccinia-related kinases, VRK1 and VRK2, bound to small-molecule inhibitors, has been reported.

  2. a novel insight into the oncogenic activity of VRK2-Akt complexes in the lysosomes via modulation of autophagy

  3. VRK2 is suggested as a candidate gene for neurological disorders through its role in signaling pathway, the neuronal loss and stress response.

  4. GSK3beta may inhibit VRK2 catalytic activity by disrupting its flexibility. The inhibition of VRK2 catalytic activity by GSK3beta may also inhibit VRK2-induced degradation of TRiC, which could suppress polyQ-expanded Htt aggregation.

  5. The combined analysis confirmed evidence of genome-wide significant associations in the Han Chinese population for three loci, at 2p16.1 (rs1051061, in an exon of VRK2, P=1.14 x 10-12, odds ratio (OR)=1.17), 6p22.1 (rs115070292 in an intron of GABBR1, P=4.96 x 10-10, OR=0.77) and 10q24.32 (rs10883795 in an intron of AS3MT, P=7.94 x 10-10, OR=0.87; rs10883765 at an intron of ARL3, P=3.06 x 10-9, OR=0.87).

  6. VRK1 AND VRK2 expression are predictive of tumor response to neoadjuvant chemoradiation therapy in rectal adenocarcinoma.

  7. Reduced VRK2 mRNA levels are involved in the underlying mechanisms in schizophrenia spectrum disorders.

  8. These data support a model in which vaccinia virus B1 and human VRK2 share additional substrates important for the replication of cytoplasmic poxviruses.

  9. we replicated one known signal in PAX8 (2.6 minutes per allele, 95% CI [1.9, 3.2], P = 5.7x10-16) and identified and replicated two novel associations at VRK2 (2.0 minutes per allele, 95% CI [1.3, 2.7], P = 1.2x10-9; and 1.6 minutes per allele, 95% CI [1.1, 2.2], P = 7.6x10-9)

  10. The data provides further evidence for the genetic contributions of VRK2 rs2312147 to schizophrenia susceptibility especially in Europeans, while further replication analyses in Asian populations are still needed. [meta-analysis]

  11. Our data provide preliminary evidence that the VRK2 gene might play a major role in the development of SCZ in the Northwest Chinese Han population.

  12. data may provide evidence for the effect of VRK2 on WM connectivity in patients with schizophrenia

  13. Findings suggest that ubiquitin-specific protease 25 (USP25) as a VRK2 substrate that acts on TRiC deubiquitination.

  14. VRK2 is crucial to regulate the ubiquitination-proteosomal degradation of eukaryotic chaperonin TCP-1 ring complex

  15. Data from molecular dynamic simulations suggest that bivalent cations play key structural roles in stabilization of VRK1/VRK2; bivalent cations have no obvious effects on VRK3. These kinases are targets in search for antineoplastic agents. [REVIEW]

  16. Low levels of VRK2A causes an increase in mitochondrial Bax protein level, leading to an increase in the release of cytochrome C and caspase activation, detected by PARP processing.

  17. Generalized epilepsies implicates susceptibility genes: CHRM3 at 1q43, VRK2 at 2p16.1, ZEB2 at 2q22.3, SCN1A at 2q24.3 and PNPO at 17q21.32.

  18. This study analyzed 5 genome-wide supported variants in a Han Chinese sample, and the variant rs2312147 at VRK2 showed significant association, which was confirmed in the meta-analysis combining multiple Asian and European.

  19. Human VRK2 is an active kinase playing a role in regulation of cancer cell invasion through the NFAT pathway and COX-2 expression.

  20. VRK2A can form a high molecular size complex with both MEK1 and KSR1; the KSR1 complex assembled and retained by VRK2A in the endoplasmic reticulum can have a modulatory effect on the signal mediated by MAPK,locally affecting the magnitude of its responses

Mouse (Murine) Vaccinia Related Kinase 2 (VRK2) Interaktionspartner

  1. VRK genes play a role during embryonic development of hematopoiesis

VRK2 Antigen-Profil

Beschreibung des Gens

This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. This gene is widely expressed in human tissues and has increased expression in actively dividing cells, such as those in testis, leukocytes, fetal liver, and carcinomas. Its protein localizes to the endoplasmic reticulum and has been shown to phosphorylate casein and undergo autophosphorylation. Multiple alternatively spliced transcript variants have been found for this gene.

Genbezeichner und Symbole assoziert mit VRK2

  • vaccinia related kinase 2 (VRK2) Antikörper
  • vaccinia related kinase 2 (Vrk2) Antikörper
  • 2810003O05Rik Antikörper
  • AI447698 Antikörper

Bezeichner auf Proteinebene für VRK2

vaccinia related kinase 2 , serine/threonine-protein kinase VRK2 , vaccinia virus B1R-related kinase 2 , vaccinia virus BIR kinase related kinase 2 , vaccinia-related kinase 2

100345223 Oryctolagus cuniculus
7444 Homo sapiens
69922 Mus musculus
360991 Rattus norvegicus
Ausgewählte Anbieter für VRK2 (VRK2) ELISA Kits
Haben Sie etwas anderes gesucht?